{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:14:12Z","timestamp":1770434052168,"version":"3.49.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1607,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> T cell lymphoproliferative disorders continue to be serious management problems, and so alternative therapeutic modalities are continuously being explored. One such strategy involves immunotherapy using the T cell receptor (TCR) as a target. Specifically we are attempting to develop a T cell receptor idiotype (TCR\u2010Id) vaccine because the TCR\u2010Id can serve as a tumor\u2010specific antigen. In this article we will briefly review the rationale for TCR\u2010Id vaccines, the preclinical models as developed in our laboratory, and a discussion of our current plans for a vaccine trial in mycosis fungoides.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03714.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:22:22Z","timestamp":1279668142000},"page":"97-105","source":"Crossref","is-referenced-by-count":11,"title":["T Cell Antigen Receptor Vaccines for Active Therapy of T Cell Malignancies"],"prefix":"10.1111","volume":"941","author":[{"given":"SUNIL A.","family":"REDDY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CRAIG","family":"OKADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARMEN","family":"WONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID","family":"BAHLER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RONALD","family":"LEVYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.4049\/jimmunol.159.11.5516","article-title":"TCR vaccines for active immunotherapy of T cell malignancies","volume":"159","author":"Okada C.Y.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.4049\/jimmunol.162.4.2251","article-title":"TCR vaccines against T cell lymphoma: QS\u201021 and IL\u201012 adjuvants induce a protective CD8+ T cell response","volume":"162","author":"Wong C.P.","year":"1999","journal-title":"J. Immunol."},{"key":"e_1_2_7_4_2","first-page":"2689","article-title":"Recombinant adenovirus vaccine encoding a chimeric T\u2010cell antigen receptor induces protective immunity against a T\u2010cell lymphoma","volume":"60","author":"Wong C.P.","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_7_5_2","first-page":"62","article-title":"Cutaneous T\u2010cell lymphoma: a model for selective immunotherapy","volume":"4","author":"Edelson R.L.","year":"1998","journal-title":"Cancer J. Sci. Am."},{"key":"e_1_2_7_6_2","first-page":"1061","article-title":"Cutaneous T\u2010cell lymphoma: pathogenesis and treatment [in process citation]","volume":"14","author":"Girardi M.","year":"2000","journal-title":"Oncology (Huntingt.)"},{"key":"e_1_2_7_7_2","first-page":"276","article-title":"Mycosis fungoides and the Sezary syndrome","volume":"26","author":"Kim Y.H.","year":"1999","journal-title":"Semin. Oncol."},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.15.2908"},{"key":"e_1_2_7_9_2","unstructured":"Abbas A.K. A.H. Lichtman & J.S. Pober. 2000. Cellular and Molecular Immunology 4th Edition. W.B. Saunders. Philadelphia."},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.141.6.2168","article-title":"Idiotypic vaccination as a treatment for a B cell lymphoma","volume":"141","author":"George A.J.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_7_11_2","first-page":"1029","article-title":"Idiotype vaccination against murine B cell lymphoma","volume":"145","author":"Campbell M.J.","year":"1990","journal-title":"Humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol."},{"key":"e_1_2_7_12_2","first-page":"2825","article-title":"Idiotype vaccination against murine B cell lymphoma","volume":"139","author":"Campbell M.J.","year":"1987","journal-title":"Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. J. Immunol."},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3129"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-52"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1342.004k19_1342_1349"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4049\/jimmunol.130.2.970","article-title":"Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation","volume":"130","author":"Stevenson F.K.","year":"1983","journal-title":"J. Immunol."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1995.tb00083.x"},{"key":"e_1_2_7_18_2","first-page":"157","article-title":"Rationale for adjuvant idiotypic vaccination after high\u2010dose therapy for multiple myeloma","volume":"3","author":"Reichardt V.L.","year":"1997","journal-title":"Biol. Blood Marrow Transplant."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.7.2411"},{"key":"e_1_2_7_20_2","first-page":"988","article-title":"Induction of humoral and cellular anti\u2010idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy","volume":"3","author":"Abe A.","year":"1996","journal-title":"Gene Ther."},{"key":"e_1_2_7_21_2","first-page":"3227","article-title":"Immunotherapy of established murine B cell lymphoma","volume":"141","author":"Campbell M.J.","year":"1988","journal-title":"Combination of idiotype immunization and cyclophosphamide. J. Immunol."},{"key":"e_1_2_7_22_2","first-page":"251","article-title":"Development of a new therapeutic approach to B cell malignancy","volume":"4","author":"Campbell M.J.","year":"1989","journal-title":"The induction of immunity by the host against cell surface receptor on the tumor. Int. Rev. Immunol."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3699"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203043060906"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/316517a0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3037698"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90079-7"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90558-2"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.6.2153"},{"key":"e_1_2_7_30_2","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.144.12.4621","article-title":"Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis","volume":"144","author":"Hashim G.A.","year":"1990","journal-title":"J. Immunol."},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1989076"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2814489"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/341541a0"},{"key":"e_1_2_7_34_2","first-page":"4940","volume":"156","author":"Chunduru S.K.","year":"1996","journal-title":"Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. J. Immunol."},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.5.1513"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00204993"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1696397"},{"key":"e_1_2_7_38_2","first-page":"1","article-title":"Diversity of T\u2010cell antigen receptor variable genes used by mycosis fungoides cells","volume":"140","author":"Bahler D.W.","year":"1992","journal-title":"Am. J. Pathol."},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(93)90132-U"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(99)00111-8"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2463672"},{"key":"e_1_2_7_42_2","unstructured":"Smart Race cDNA Amplification Kit User Manual. 1999. Clontech Laboratories. Palo Alto CA."},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.2144\/96213pf02"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/27.6.1558"},{"key":"e_1_2_7_45_2","first-page":"1134","article-title":"TaqStart Antibody: \u201chot start\u201d PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase","volume":"16","author":"Kellogg D.E.","year":"1994","journal-title":"Biotechniques"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.14.4008"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03714.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03714.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:31:10Z","timestamp":1695655870000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03714.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03714.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03714.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}